Annual report [Section 13 and 15(d), not S-K Item 405]

Description of Business - Additional Information (Details)

v3.26.1
Description of Business - Additional Information (Details)
12 Months Ended
Dec. 31, 2025
US [Member]  
Description Of Business [Line Items]  
Orphan drug designation provides marketing exclusivity period 7 years